PIK3CA and breast cancer: In a recent study [86], PIK3CA hotspot mutations were assessed in CTCs (using the CellSearch® system) and paired ctDNA, in 56 samples from 43 patients with early BC and in 27 samples from 16 patients with metastatic BC.